BMPR2 and pulmonary arterial hypertension: In our study, a reduced BMPR2 mRNA expression was also observed in trend in BMPR2 non-carriers suffering from PAH in comparison to healthy controls, suggesting that there could be different pathomechanisms reducing BMPR2 mRNA expression apart from pathogenic BMPR2 variants [6].